We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Integumen Plc | LSE:SKIN | London | Ordinary Share | GB00BMGWZY29 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 28.00 | 28.00 | 29.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/9/2018 11:24 | Jgb. Looks as if the rns has had the reverse effect to both skin & venn's sp | cocker | |
17/9/2018 12:09 | IMO for me , it would be very good to know many tests were carried out in H1 ''Labskin has successfully moved from selling Labskin equipment supplies to being a fully fledged service provider during H2 2018, increasing our orders by 350% over H1.'' Not only the Cosmetics Industry could be interested in this product re animals testing ban But , animal testing bans could follow in the Pharmaceutical Industry re new compounds pre clinical testing . Plus there is the Chemical Industry , which SKIN should approach to offer their services Over 10,000 chemical products in the USA alone now being used within the Food, Drinks , Clothes , furniture, and a host of other consumer related industries. Trump is a problem however re his EPA stance. | buywell3 | |
17/9/2018 11:31 | Not a single post after today's news? | cocker | |
03/9/2018 15:56 | All I know is I've dropped over 90 bloody percent on these poxy shares... | philoosh | |
03/9/2018 09:25 | Now it's definitely Alltracel all over again! Brandon and Richardson. How much money did shareholders lose on Alltracel from IPO to when it was finally sold for a lot less? | lbo | |
29/8/2018 12:57 | On paper a very good reply which does look as if one is being rather generous to shareholders. However, if the share price stays the same for the next 12 months then the pair of you get between you 135 million shares. Is that fair? | cocker | |
29/8/2018 10:22 | SKIN mrk cap 1.6 mill at 0.6p per share. A 347% jump in revenue would be impressive if 49k wasn't the starting point. Yes its a start but exactly how much does skin need a year to cover overheads. Some small bits of positivity here but reality is more funds likely before long. Correct me if I am wrong GJB | cocker | |
29/8/2018 08:05 | An absolute dog! | lbo | |
20/7/2018 16:29 | Thanks for your replies I will ponder | buywell3 | |
20/7/2018 15:59 | Who are the main shareholders now of Cellulac ? | buywell3 | |
20/7/2018 12:02 | So do Integumen SKIN own 100% of Cellulac ? | buywell3 | |
18/7/2018 15:04 | I went for a few shares in the placing, admittedly it is a bit of a punt, but the results were always going to be a kitchen sink job and the market cap (pre-money) of £1.4m looked attractive. I was informed by the broker that the placing shares should qualify for EIS tax relief, so that provides a reassuring safety net, so good luck gjb I hope you succeed. | timbo003 | |
18/7/2018 13:43 | What has happened ? Dalkey-based health tech firm in reverse takeover Integumen and Cellulac set to combine with a £7.5m share placing in the pipeline Dalkey-based listed health-tech company Integumen has agreed a deal to acquire Cellulac, | buywell3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions